Squarepoint’s ImageneBio Inc IMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-48,237
Closed -$333K 4585
2025
Q4
$333K Buy
48,237
+24,067
+100% +$178K ﹤0.01% 3514
2025
Q3
$197K Buy
24,170
+17,113
+242% +$227K ﹤0.01% 3953
2025
Q2
$113K Buy
7,057
+604
+9% +$8.87K ﹤0.01% 4140
2025
Q1
$99.1K Buy
6,453
+2,816
+77% +$48.6K ﹤0.01% 4222
2024
Q4
$71.6K Buy
+3,637
New +$73.5K ﹤0.01% 4772
2024
Q3
Sell
-2,306
Closed -$45.6K 4366
2024
Q2
$45.6K Buy
+2,306
New +$40.7K ﹤0.01% 3911
2021
Q2
Sell
-1,147
Closed -$389K 3447
2021
Q1
$389K Buy
+1,147
New +$393K ﹤0.01% 2209

Other funds holding IMA

Squarepoint's IMA Position: Q1 2026 in Review

Squarepoint sold out of ImageneBio Inc (IMA) in Q1 2026, closing a stake of 48,237 shares — an estimated $333K sold.

Squarepoint first reported a position in IMA in Q1 2021 and held it in 7 quarters. The position peaked at $389K in Q1 2021. 39 funds tracked by Wall St. Rank hold IMA as of Q1 2026.

  • Squarepoint reported no remaining ImageneBio Inc position as of Q1 2026 after selling out during the quarter.
  • Squarepoint sold 48,237 ImageneBio Inc shares in Q1 2026, an estimated $333K.
  • Squarepoint first reported a position in ImageneBio Inc in Q1 2021 and held it in 7 quarters.
  • Squarepoint's ImageneBio Inc position peaked at $389K in Q1 2021.
  • 39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.